These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 27139494

  • 1. A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.
    Jäger MD, Vondran FW, Ramackers W, Röseler T, Schlitt HJ, Bektas H, Klempnauer J, Timrott K.
    PLoS One; 2016; 11(5):e0154682. PubMed ID: 27139494
    [Abstract] [Full Text] [Related]

  • 2. In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody.
    Dahlke MH, Lauth OS, Jäger MD, Roeseler T, Timrott K, Jackobs S, Neipp M, Wonigeit K, Schlitt HJ.
    Blood; 2002 May 15; 99(10):3566-72. PubMed ID: 11986209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats.
    Neipp M, Exner BG, Maru D, Haber M, Gammie JS, Pham SM, Ildstad ST.
    Exp Hematol; 1999 May 15; 27(5):860-7. PubMed ID: 10340402
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX, Fan LY, Wang Q.
    Eur Surg Res; 2011 May 15; 46(3):109-17. PubMed ID: 21242693
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.
    Brenner MK, Wulf GG, Rill DR, Luo KL, Goodell MA, Mei Z, Kuehnle I, Brown MP, Pule M, Heslop HE, Krance RA.
    Ann N Y Acad Sci; 2003 May 15; 996():80-8. PubMed ID: 12799286
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
    Tomita Y, Sachs DH, Sykes M.
    Blood; 1994 Feb 15; 83(4):939-48. PubMed ID: 7906567
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
    Chen Y, Kornblit B, Hamlin DK, Sale GE, Santos EB, Wilbur DS, Storer BE, Storb R, Sandmaier BM.
    Blood; 2012 Feb 02; 119(5):1130-8. PubMed ID: 22134165
    [Abstract] [Full Text] [Related]

  • 14. Manipulation of CD45 antigen in transplantation tolerance.
    Ko S, Jaeger MD, Dahlke MH, Nakajima Y, Schlitt HJ.
    Curr Mol Med; 2002 May 02; 2(3):249-55. PubMed ID: 12041728
    [Abstract] [Full Text] [Related]

  • 15. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H, Chilton PM, Huang Y, Schanie CL, Yan J, Ildstad ST.
    Transplantation; 2007 Apr 15; 83(7):954-63. PubMed ID: 17460568
    [Abstract] [Full Text] [Related]

  • 16. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN, Lee J, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Kwon CH, Joh JW, Kim SJ.
    J Surg Res; 2006 Jan 15; 130(1):102-9. PubMed ID: 16183077
    [Abstract] [Full Text] [Related]

  • 17. The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
    Barsoukov AA, Moore PF, Storb R, Santos EB, Sandmaier BM.
    Transplantation; 1999 May 27; 67(10):1329-35. PubMed ID: 10360586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
    Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA.
    Xenotransplantation; 2006 May 27; 13(3):224-32. PubMed ID: 16756565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.